DE69925225D1 - Propylaxe und behandlung der arzneimittel induzierten nierenstörungen - Google Patents

Propylaxe und behandlung der arzneimittel induzierten nierenstörungen

Info

Publication number
DE69925225D1
DE69925225D1 DE69925225T DE69925225T DE69925225D1 DE 69925225 D1 DE69925225 D1 DE 69925225D1 DE 69925225 T DE69925225 T DE 69925225T DE 69925225 T DE69925225 T DE 69925225T DE 69925225 D1 DE69925225 D1 DE 69925225D1
Authority
DE
Germany
Prior art keywords
propylaxis
treatment
medicinal products
kidney disorders
products induced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69925225T
Other languages
English (en)
Other versions
DE69925225T2 (de
Inventor
Mikio Okamura
Yoshiharu Kanayama
Junichi Yoshikawa
Haruo Shintaku
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Daiichi Sankyo Co Ltd
Original Assignee
Daiichi Suntory Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Suntory Pharma Co Ltd filed Critical Daiichi Suntory Pharma Co Ltd
Application granted granted Critical
Publication of DE69925225D1 publication Critical patent/DE69925225D1/de
Publication of DE69925225T2 publication Critical patent/DE69925225T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69925225T 1998-02-27 1999-02-26 Propylaxe und behandlung der arzneimittel induzierten nierenstörungen Expired - Lifetime DE69925225T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP4815898 1998-02-27
JP4815898 1998-02-27
PCT/JP1999/000916 WO1999043324A1 (fr) 1998-02-27 1999-02-26 Agents prophylactiques ou remedes contre les troubles renaux d'origine medicamenteuse

Publications (2)

Publication Number Publication Date
DE69925225D1 true DE69925225D1 (de) 2005-06-16
DE69925225T2 DE69925225T2 (de) 2006-02-23

Family

ID=12795582

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925225T Expired - Lifetime DE69925225T2 (de) 1998-02-27 1999-02-26 Propylaxe und behandlung der arzneimittel induzierten nierenstörungen

Country Status (7)

Country Link
US (1) US6288067B1 (de)
EP (1) EP1004308B1 (de)
JP (1) JP4486167B2 (de)
AT (1) ATE295172T1 (de)
DE (1) DE69925225T2 (de)
ES (1) ES2242381T3 (de)
WO (1) WO1999043324A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0908182B2 (de) * 1996-08-30 2007-03-28 Daiichi Asubio Pharma Co., Ltd. Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst sind
CA2545584C (en) * 2003-11-17 2012-10-23 Biomarin Pharmaceutical Inc. Methods and compositions for the treatment of metabolic disorders
CA2581814C (en) * 2004-11-17 2015-10-13 Biomarin Pharmaceutical Inc. Stable tablet formulation of tetrahydrobiopterin
KR20100016445A (ko) 2007-04-11 2010-02-12 바이오마린 파머수티컬 인크. 테트라하이드로바이오프테린 투여 방법, 관련 조성물 및 측정 방법
US20140050728A1 (en) * 2011-01-28 2014-02-20 Board Of Regents Of The University Of Nebraska Methods and compositions for inhibiting cyclophilin d for the treatment and prevention of obesity and kidney indications
US9216178B2 (en) 2011-11-02 2015-12-22 Biomarin Pharmaceutical Inc. Dry blend formulation of tetrahydrobiopterin
WO2018139842A1 (ko) * 2017-01-24 2018-08-02 주식회사 우성제약 아세트아미노펜을 함유하는 주사제 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5925323A (ja) * 1982-03-03 1984-02-09 鐘淵化学工業株式会社 プテリン誘導体からなる脳内神経伝達物質の関わる疾病の治療剤
ZA836957B (en) * 1982-09-20 1985-04-24 Wellcome Found Neurologically active chemical compounds
JPS61277618A (ja) * 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
JPH02157755A (ja) 1988-12-09 1990-06-18 Daito Denshi Color Kk 自動給液システム
AU9084991A (en) * 1990-11-01 1992-05-26 Board Of Regents, The University Of Texas System Antifungal activity of and prevention of drug induced nephrotoxicity by methylxanthine analogues
JPH0656669A (ja) * 1992-06-11 1994-03-01 Asahi Breweries Ltd 活性酸素消去作用を持つプテリン誘導体製剤
EP0908182B2 (de) * 1996-08-30 2007-03-28 Daiichi Asubio Pharma Co., Ltd. Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst sind

Also Published As

Publication number Publication date
ATE295172T1 (de) 2005-05-15
DE69925225T2 (de) 2006-02-23
ES2242381T3 (es) 2005-11-01
EP1004308A1 (de) 2000-05-31
EP1004308A4 (de) 2001-03-14
JP4486167B2 (ja) 2010-06-23
US6288067B1 (en) 2001-09-11
EP1004308B1 (de) 2005-05-11
WO1999043324A1 (fr) 1999-09-02

Similar Documents

Publication Publication Date Title
DE69526918T2 (de) Arzneimittel gegen spinocerebellare degeneration
WO2001072728A3 (en) Novel piperazine derivatives
EP0795548A4 (de) Chinazozin derivate und deren verwendung
EP0908182A4 (de) Vorbeugende oder heilende mittel für krankheiten, die durch mangel an stickoxid-synthase (nos) ausgelöst ist
WO2002032900A3 (en) Aryl or heteroaryl fused imidazole compounds as anti-inflammatory and analgesic agents
NO950297L (no) Prolinamidderivater
EP0928789A4 (de) 6-phenyltetrahydro-1,3-oxazin-2-on derivate und medizinische zusammensetzungen, die sie enthalten
IL120584A (en) 1,2-diphenylpyrrole derivatives, use thereof for the manufacture of a medicament and pharmaceutical compositions containing the same
ATE260263T1 (de) Heteroaromatische bizyklische verbindungen mit antikrebswirkung
WO1998035951A3 (en) New aminopiperazine derivatives
DK0738152T3 (da) Anvendelse af 2-hydroxy-5-phenylazobenzoesyrederivater som kemopræventive og kemoterapeutiske midler mod coloncancer
WO1999012532A3 (en) Piperidine derivatives against malaria
EP1182193A4 (de) Medikamente gegen neuropathische schmerzen
GEP20053617B (en) Bridged Piperazine Derivatives
EP1329218A4 (de) Wirkstoffe zur vorbeugung und behandlung portaler hypertonie
DE69925225D1 (de) Propylaxe und behandlung der arzneimittel induzierten nierenstörungen
ATE340575T1 (de) Vorbeugung und behandlung von krankheiten in zusammenhang zu vaskularen funktionellen stoerungen un verbindung mit insulinresistenz
GEP20043227B (en) 5HT1 Antagonists for Antidepressant Therapy
WO2002026732A1 (fr) Derive de benzodiazepine
DE69828197D1 (de) Amidderivate zur behandlung neurodegenerativer erkrankungen der netzhaut
GEP20063759B (en) Novel Benzothiazine and Benzothiadiazine Derivatives, Method for Preparing Same and Pharmaceutical Compositions Containing Same
NO964497D0 (no) Middel for behandling av cor pulmonale
EP0201349A3 (de) Tetrazolderivate
DK0784973T3 (da) Quinoxalinderivater til behandling af tinnitus
DE69528984D1 (de) Hemmung der leukotrienbiosynthese mittels harnstoffderivaten

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP

8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ASUBIO PHARMA CO., LTD., TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI SANKYO COMPANY, LIMITED, TOKIO, JP